Francis Prisco
Other staff cuts in sight for the pharmaceutical sector: the merger between Takeda Italia Farmaceutici and Nycomed spa will in fact lead to the closure of the Milan office of the second company, where 42 employees currently work.
And so "a staff reduction procedure" is envisaged, on the basis of Law 223/91 which regulates mobility, "which will be implemented prior to the effectiveness of the merger".
This is learned from a letter sent by the two companies to the social partners on June 28 to take stock of the incorporation plan which will lead, in all probability as early as December 1 of this year, to the birth of Takeda Italia spa, a new subject operating in Italy of the Japanese big pharma.
The sense of the operation, reads the letter, is "to concentrate and rationalize the resources of the companies involved". With obvious employment impacts: "The closure of the Milan office of the incorporating company (while the Cerano plant and the Rome offices of the incorporated company will remain operational), the duplication of professional roles and the overlapping of pharmaceutical products and lean representatives in the same geographical areas, with consequent possible redundancies".
For Fabrizio Rigoldi [in the picture] of Ugl CHEMISTICS Lombardia: «We are faced with the umpteenth reduction of jobs in the Lombard pharmaceutical district and in the scientific information sector, which has already lost about 15,000 workers in the last five years alone».
04-07-2012 The sun 24 hours
Nycomed spa,
